Anavex Life Sciences (AVXL)
(Real Time Quote from BATS)
$6.47 USD
-0.11 (-1.67%)
Updated Aug 2, 2024 02:58 PM ET
3-Hold of 5 3
C Value C Growth A Momentum C VGM
Brokerage Reports
0 items in cart
Anavex Life Sciences Corp. [AVXL]
Reports for Purchase
Showing records 101 - 120 ( 157 total )
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
ANAVEX?3-71 Enters First-in-Human Phase 1 Trial; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
BUY-Anavex 3-71 in Man for Frontotemporal Dementia-FTD
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
Parkinson''s Data Imminent; F2Q20 Financial Results; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
Steady as She Goes; Clinical Progress Despite COVID-19; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
We are initiating coverage with a Buy rating and 12-month price target of $12.00 per share
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
Did You See the Move in Biogen This Time Back Down?
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
Company: Anavex Life Sciences Corp.
Industry: Medical - Biomedical and Genetics
We are dropping coverage of AVXL to reallocate our research resources.
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S